BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 16798702)

  • 1. Comparison of two vaccination programmes in preventing influenza-related hospitalization among the elderly during two consecutive seasons.
    Honkanen P; Läärä E; Pyhälä R; Kivelä SL; Helena Mäkelä P
    Scand J Infect Dis; 2006; 38(6-7):506-11. PubMed ID: 16798702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing medical service utilization by encouraging vaccines: randomized controlled trial.
    Berg GD; Thomas E; Silverstein S; Neel CL; Mireles M
    Am J Prev Med; 2004 Nov; 27(4):284-8. PubMed ID: 15488357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza and pneumococcal vaccination levels among persons aged > or = 65 years--United States, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Jun; 50(25):532-7. PubMed ID: 11446571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly.
    Nichol KL; Nordin J; Mullooly J; Lask R; Fillbrandt K; Iwane M
    N Engl J Med; 2003 Apr; 348(14):1322-32. PubMed ID: 12672859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons.
    Blank PR; Schwenkglenks M; Szucs TD
    J Infect; 2009 Jun; 58(6):446-58. PubMed ID: 19446340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of bias in estimates of influenza vaccine effectiveness in seniors.
    Jackson LA; Jackson ML; Nelson JC; Neuzil KM; Weiss NS
    Int J Epidemiol; 2006 Apr; 35(2):337-44. PubMed ID: 16368725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza- and RSV-associated hospitalizations among adults.
    Mullooly JP; Bridges CB; Thompson WW; Chen J; Weintraub E; Jackson LA; Black S; Shay DK;
    Vaccine; 2007 Jan; 25(5):846-55. PubMed ID: 17074423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons.
    Nichol KL; Nordin J; Mullooly J
    Vaccine; 2006 Mar; 24(10):1562-8. PubMed ID: 16300868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older.
    Baxter R; Ray GT; Fireman BH
    Vaccine; 2010 Oct; 28(45):7267-72. PubMed ID: 20832494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan.
    Cai L; Uchiyama H; Yanagisawa S; Kamae I
    Kobe J Med Sci; 2006; 52(3-4):97-109. PubMed ID: 16855372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of influenza epidemics on hospitalizations.
    Simonsen L; Fukuda K; Schonberger LB; Cox NJ
    J Infect Dis; 2000 Mar; 181(3):831-7. PubMed ID: 10720501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over.
    Kelly H; Attia J; Andrews R; Heller RF
    Vaccine; 2004 Jun; 22(17-18):2192-8. PubMed ID: 15149776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age.
    Puig-Barberà J; Diez-Domingo J; Pérez Hoyos S; Belenguer Varea A; González Vidal D
    Vaccine; 2004 Dec; 23(3):283-9. PubMed ID: 15530669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing major cause-specific hospitalization rates and shortening hospital stays after influenza vaccination.
    Wang CS; Wang ST; Lai CT; Lin LJ; Lee CT; Chou P
    Clin Infect Dis; 2004 Dec; 39(11):1604-10. PubMed ID: 15578359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In a prospective observational study, influenza vaccination prevented hospitalization among older home care patients.
    Landi F; Onder G; Cesari M; Russo A; Barillaro C; Bernabei R; ; Gambassi G; Manigrasso L; Pagano F; Gobbi C
    J Clin Epidemiol; 2006 Oct; 59(10):1072-7. PubMed ID: 16980147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccine effectiveness among elderly persons living in the community during the 2003--2004 season.
    Hara M; Sakamoto T; Tanaka K
    Vaccine; 2008 Nov; 26(50):6477-80. PubMed ID: 18573296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program.
    Jansen AG; Sanders EA; Nichol KL; van Loon AM; Hoes AW; Hak E
    Vaccine; 2008 Oct; 26(44):5567-74. PubMed ID: 18722492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations.
    Hak E; Nordin J; Wei F; Mullooly J; Poblete S; Strikas R; Nichol KL
    Clin Infect Dis; 2002 Aug; 35(4):370-7. PubMed ID: 12145718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.